Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.
Xia, Yi; Jeffrey Medeiros, L; Young, Ken H.
Biochim Biophys Acta
; 1865(1): 58-71, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26432723
Check this checkpoint inhibitor in lymphoma.
Les immune-checkpoints dans les hémopathies.
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
PD-1 blockade therapy in lymphoid malignancies.
Mechanisms of Immune Tolerance in Leukemia and Lymphoma.
PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas.
Programmed cell death-1 inhibition in lymphoma.
Targeting immune checkpoints in lymphoma.
Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma.
Cancer immunotherapy: enthusiasm and reality aligning at last.